These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22277410)

  • 1. [Registry of muscular dystrophy (Remudy). Construction of the patient self-report registry and collaboration with overseas network].
    Nakamura H; Kawai M
    Rinsho Shinkeigaku; 2011 Nov; 51(11):901-2. PubMed ID: 22277410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Infrastructure for new drug development to treat muscular dystrophy: current status of patient registration (remudy)].
    Nakamura H; Kimura E; Kawai M
    Brain Nerve; 2011 Nov; 63(11):1279-84. PubMed ID: 22068481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of Japanese Duchenne and Becker muscular dystrophy patients in a novel Japanese national registry of muscular dystrophy (Remudy).
    Nakamura H; Kimura E; Mori-Yoshimura M; Komaki H; Matsuda Y; Goto K; Hayashi YK; Nishino I; Takeda S; Kawai M
    Orphanet J Rare Dis; 2013 Apr; 8():60. PubMed ID: 23601510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trial network for the promotion of clinical research for rare diseases in Japan: muscular dystrophy clinical trial network.
    Shimizu R; Ogata K; Tamaura A; Kimura E; Ohata M; Takeshita E; Nakamura H; Takeda S; Komaki H
    BMC Health Serv Res; 2016 Jul; 16():241. PubMed ID: 27401940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Infrastructure for the clinical research of muscular dystrophies: remudy and MDCTN].
    Kimura E; Nakamura H; Mitsuhashi S; Takeuchi F; Mori-Yoshimura M; Shimizu R; Komaki H; Hayashi YK; Nishino I; Kawai M; Takeda S
    Rinsho Shinkeigaku; 2014; 54(12):1069-70. PubMed ID: 25519964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Remudy].
    Kimura E; Nakamura H; Nishino I
    Brain Nerve; 2014 Nov; 66(11):1396-402. PubMed ID: 25407075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive database of Duchenne and Becker muscular dystrophy patients (0-18 years old) in East China.
    Li X; Zhao L; Zhou S; Hu C; Shi Y; Shi W; Li H; Liu F; Wu B; Wang Y
    Orphanet J Rare Dis; 2015 Jan; 10():5. PubMed ID: 25612904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iranian Registry of Duchenne and Becker Muscular Dystrophies: Characterization and Preliminary Data.
    Bayat F; Sarmiento IG; Ahmadian N; Dehghani Z
    J Neuromuscul Dis; 2021; 8(2):251-259. PubMed ID: 33325392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the DMD/BMD patient population in Czech Republic and Slovakia using an innovative registry approach.
    Brabec P; Vondrácek P; Klimes D; Baumeister S; Lochmüller H; Pavlík T; Gregor J
    Neuromuscul Disord; 2009 Apr; 19(4):250-4. PubMed ID: 19269824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The TREAT-NMD Duchenne muscular dystrophy registries: conception, design, and utilization by industry and academia.
    Bladen CL; Rafferty K; Straub V; Monges S; Moresco A; Dawkins H; Roy A; Chamova T; Guergueltcheva V; Korngut L; Campbell C; Dai Y; Barišić N; Kos T; Brabec P; Rahbek J; Lahdetie J; Tuffery-Giraud S; Claustres M; Leturcq F; Ben Yaou R; Walter MC; Schreiber O; Karcagi V; Herczegfalvi A; Viswanathan V; Bayat F; de la Caridad Guerrero Sarmiento I; Ambrosini A; Ceradini F; Kimura E; van den Bergen JC; Rodrigues M; Roxburgh R; Lusakowska A; Oliveira J; Santos R; Neagu E; Butoianu N; Artemieva S; Rasic VM; Posada M; Palau F; Lindvall B; Bloetzer C; Karaduman A; Topaloğlu H; Inal S; Oflazer P; Stringer A; Shatillo AV; Martin AS; Peay H; Flanigan KM; Salgado D; von Rekowski B; Lynn S; Heslop E; Gainotti S; Taruscio D; Kirschner J; Verschuuren J; Bushby K; Béroud C; Lochmüller H
    Hum Mutat; 2013 Nov; 34(11):1449-57. PubMed ID: 23913485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Italian neuromuscular registry: a coordinated platform where patient organizations and clinicians collaborate for data collection and multiple usage.
    Ambrosini A; Calabrese D; Avato FM; Catania F; Cavaletti G; Pera MC; Toscano A; Vita G; Monaco L; Pareyson D
    Orphanet J Rare Dis; 2018 Oct; 13(1):176. PubMed ID: 30286784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Establishment of an evaluation method for muscular dystrophy and a patient registration system for clinical trials].
    Kawai M
    Rinsho Shinkeigaku; 2009 Nov; 49(11):863-6. PubMed ID: 20030232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Dutch Dystrophinopathy Database: A National Registry with Standardized Patient and Clinician Reported Real-World Data.
    van de Velde NM; Krom YD; Bongers J; Hoek RJA; Ikelaar NA; van der Holst M; Naarding KJ; van den Bergen JC; Vroom E; Horemans A; Hendriksen JGM; de Groot IJM; Houwen-van Opstal SLS; Verschuuren JJGM; van Duyvenvoorde HA; Snijder RR; Niks EH
    J Neuromuscul Dis; 2024; 11(5):1095-1109. PubMed ID: 39031379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Muscular Dystrophy Association's neuroMuscular ObserVational Research Data Hub (MOVR): Design, Methods, and Initial Observations.
    Kilroy EA; Burris R; Javelosa E; Waits J; Lek A; Rodgers R; Opgenorth H; Hesterlee S
    J Neuromuscul Dis; 2023; 10(3):365-380. PubMed ID: 36911943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Social involvement issues in patients with Becker muscular dystrophy: A questionnaire survey of subjects from a patient registry.
    Mori-Yoshimura M; Mizuno Y; Yoshida S; Minami N; Yonemoto N; Takeuchi F; Nishino I; Murata M; Takeda S; Takahashi Y; Kimura E
    Brain Dev; 2018 Apr; 40(4):268-277. PubMed ID: 29196072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis for genetic diagnosis of Dystrophinopathies in Japan.
    Okubo M; Goto K; Komaki H; Nakamura H; Mori-Yoshimura M; Hayashi YK; Mitsuhashi S; Noguchi S; Kimura E; Nishino I
    Orphanet J Rare Dis; 2017 Aug; 12(1):149. PubMed ID: 28859693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A checklist for clinical trials in rare disease: obstacles and anticipatory actions-lessons learned from the FOR-DMD trial.
    Crow RA; Hart KA; McDermott MP; Tawil R; Martens WB; Herr BE; McColl E; Wilkinson J; Kirschner J; King WM; Eagle M; Brown MW; Hirtz D; Lochmuller H; Straub V; Ciafaloni E; Shieh PB; Spinty S; Childs AM; Manzur AY; Morandi L; Butterfield RJ; Horrocks I; Roper H; Flanigan KM; Kuntz NL; Mah JK; Morrison L; Darras BT; von der Hagen M; Schara U; Wilichowski E; Mongini T; McDonald CM; Vita G; Barohn RJ; Finkel RS; Wicklund M; McMillan HJ; Hughes I; Pegoraro E; Bryan Burnette W; Howard JF; Thangarajh M; Campbell C; Griggs RC; Bushby K; Guglieri M
    Trials; 2018 May; 19(1):291. PubMed ID: 29793540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene deletions in Japanese patients with Duchenne and Becker muscular dystrophy.
    Asano J; Tomatsu S; Sukegawa K; Yamaguchi S; Ikedo Y; Minami R; Iida M; Nishimura M; Nakagawa M; Ohshiro M
    Jinrui Idengaku Zasshi; 1990 Jun; 35(2):159-68. PubMed ID: 2398631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and mutational characteristics of Duchenne muscular dystrophy patients based on a comprehensive database in South China.
    Wang DN; Wang ZQ; Yan L; He J; Lin MT; Chen WJ; Wang N
    Neuromuscul Disord; 2017 Aug; 27(8):715-722. PubMed ID: 28318817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The French National Registry of patients with Facioscapulohumeral muscular dystrophy.
    Guien C; Blandin G; Lahaut P; Sanson B; Nehal K; Rabarimeriarijaona S; Bernard R; Lévy N; Sacconi S; Béroud C
    Orphanet J Rare Dis; 2018 Dec; 13(1):218. PubMed ID: 30514324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.